Resveratrol’s inhibition of the serine/threonine protein kinase Akt has been identified in anti-cancer activity modulated by the activation of FOXO3a in human breast cancer cells, because FOXO3a was not found to be activated by Akt [140]. The gene discussed is FOXO3; the disease is breast carcinoma.